优化"线性"约束,以改善局部复发性鼻癌的剂量分配,使用基于知识的规划
Xiaoli Yu1,2, Yixuan Wang1, Mingli Wang1
1State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Department of Radiation Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
Technology in cancer research & treatment
|June 18, 2025
概括
基于知识的规划 (KBP) 模型显著改善了复发性鼻癌 (rNPC) 的放射治疗,通过更好地保护器官,增强目标统一性,减少机构之间的治疗规划变化. 这种方法提供了一个更一致,更有效的精确反辐射策略.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 癌症治疗方法 癌症治疗方法
背景情况:
- 复发性鼻癌 (rNPC) 对有效的再辐射提出了挑战.
- 优化剂量分配和最大限度地减少放射治疗计划的机构间差异对于改善患者的治疗结果至关重要.
- 强度调节放射治疗 (IMRT) 是对rNPC的标准治疗方式.
研究的目的:
- 评估基于知识的规划 (KBP) 模型在优化rNPC再辐射剂量分配方面的有效性.
- 识别和量化对rNPC的放射治疗计划的机构间变化.
- 为了比较KBP生成的计划与手动优化计划的剂量测量和效率结果.
主要方法:
- 使用70名接受IMRT治疗的rNPC患者的数据开发了一个KBP模型.
- 36名患者的验证队列进行了手动和KBP计划之间的剂量测量比较.
- 来自六所机构的十名物理学家独立规划了一个代表性案例,以评估机构间的变化.
主要成果:
- KBP模型显著降低了对有风险的器官 (OARs) 的辐射剂量,包括脑干和脊髓.
- 与手动计划相比,KBP计划显示了更好的目标均性和消除了热点.
- 实施KBP减少了大脑干和脊髓的机构间剂量差异,并将计划效率提高了48.7%.
结论:
- 该KBP框架增强了OAR保护,提高了目标均性,并增加了多机构一致性和计划效率,用于rNPC再辐射.
- KBP建立了用于精密再辐射的临床可操作范式,解决了剂量优化和机构间可变性的关键挑战.
- 这种方法在改善头癌复发的放射治疗质量和一致性方面具有显著的前景.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Dosage Regimen: Overview
4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Nonlinear Pharmacokinetics: Overview
1.4K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.4K
Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
Dosage Regimen: Individualization
398
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
398
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394


